# Medtap

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medtap

- Industry: Healthcare Specialists
- Headquarters: Hangzhou, China
- Website: www.iplusmed.com
- Total disclosed funding: $2.5M
- Latest round: Series A (May 20, 2015)
- Investors on record: 3

## About

Established in 2014 and based in Hangzhou, China, Medtap operates as a medical platform dedicated to providing cancer diagnosis and related services. It acquired certifications such as National High-tech Enterprise Certificate and Internet Drug Information Service Certificate. The founder and CEO of the company, Yi Xu has worked in BMS and Roche. In May 2015, the company closed CNY 15 million in series A funding led by new investor Shanghai China Healthcare Venture Management.

The company mainly provides doctor-patient communication services in the field of oncology. Medtap mainly provides a mobile medical APP in the field of oncology named Yijiayi. The application has functions such as doctor-patient communication, one-on-one, and finding resources to provide patients and their families with services such as doctor-patient communication and online consultation. Medtap also provides services such as 3650 screening, tumour prevention, and overseas medical treatment.

## Funding rounds

- Series A, May 20, 2015, $2.5M — GP Capital, Shanghai China Healthcare Venture Management, Tigermed

## Investors

- GP Capital (https://capitalatlas.ai/funds/gp-capital) — Series A
- Shanghai China Healthcare Venture Management (https://capitalatlas.ai/funds/shanghai-china-healthcare-venture-management) — Series A
- Tigermed (https://capitalatlas.ai/funds/tigermed) — Series A